One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2019-129962
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 3 |
Affiliation: Yale University, Columbia University Irving Medical Center, Princess Margaret Cancer Centre, Temple University, The University of Texas MD Anderson Cancer Center, Mayo Clinic, Cornell University, Presbyterian Hospital, Sarah Cannon, University of Chicago Medical Center, Roswell Park Cancer Institute, Vanderbilt University, University of Southern California, The Ohio State UniversityLandmark Response and Survival Analyses from 102 MDS and CMML Patients Treated with Guadecitabine in a Phase 2 Study Showing That Maximum Response and Survival Is Best Achieved with Adequate Treatment Duration
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
